1. Home
  2. PRAX vs IBP Comparison

PRAX vs IBP Comparison

Compare PRAX & IBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$337.29

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Logo Installed Building Products Inc.

IBP

Installed Building Products Inc.

HOLD

Current Price

$276.26

Market Cap

8.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
IBP
Founded
2015
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.2B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
PRAX
IBP
Price
$337.29
$276.26
Analyst Decision
Strong Buy
Hold
Analyst Count
15
8
Target Price
$572.13
$266.14
AVG Volume (30 Days)
326.2K
276.6K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
1.18%
EPS Growth
N/A
6.70
EPS
N/A
9.71
Revenue
N/A
$2,970,800,000.00
Revenue This Year
N/A
$1.96
Revenue Next Year
$7,758.26
$4.32
P/E Ratio
N/A
$29.87
Revenue Growth
N/A
1.00
52 Week Low
$34.89
$150.83
52 Week High
$354.87
$349.00

Technical Indicators

Market Signals
Indicator
PRAX
IBP
Relative Strength Index (RSI) 55.91 42.10
Support Level $282.49 $254.38
Resistance Level $353.83 $277.05
Average True Range (ATR) 18.75 10.99
MACD -0.96 -1.75
Stochastic Oscillator 69.67 2.95

Price Performance

Historical Comparison
PRAX
IBP

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About IBP Installed Building Products Inc.

Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.

Share on Social Networks: